NCT03695913

Brief Summary

This study will recruit pre-diabetic patients to see if continuous glucose monitoring (CGM) with a low carbohydrate diet can reduce the percentage of time the CGM readings are above the normal range. Through this study it will demonstrate the feasibility of using CGM with a low carbohydrate diet to reduce weight and risk of developing diabetes in patients with pre-diabetes. Patients that appear to be eligible will be recruited from Michigan Medicine in the Family Medicine Clinic at the Livonia Center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
12 days until next milestone

Study Start

First participant enrolled

October 16, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2019

Completed
6 months until next milestone

Results Posted

Study results publicly available

March 16, 2020

Completed
Last Updated

March 16, 2020

Status Verified

February 1, 2020

Enrollment Period

5 months

First QC Date

October 2, 2018

Results QC Date

February 10, 2020

Last Update Submit

March 12, 2020

Conditions

Keywords

Pre-diabetes, low carbohydrate diet

Outcome Measures

Primary Outcomes (2)

  • Participant Satisfaction With Continuous Glucose Monitoring (CGM)

    Satisfaction is measured using responses to the post intervention survey question, "How likely are you to recommend that a friend or family member with pre-diabetes wear a continuous glucose monitor (CGM)?". A 5 point scale was used, ranging from 1 to 5, where a score of 1 is "extremely likely" and 5 is "would not recommend". Satisfied respondents answered either 1 or 2 on the scale.

    33 days after day 1 (visit 3 completion)

  • Participant Satisfaction With Continuous Glucose Monitoring

    Common qualitative themes related to participant satisfaction with CGM from post intervention interview were coded.

    60 days (30 days after visit 3 completion)

Secondary Outcomes (10)

  • Feasibility, Measured by Recruitment

    3 months

  • Feasibility of Pre-diabetic Patients to Wear CGM Sensors

    completed within 60 days of enrollment

  • Weight Change

    day 11 (visit 2), day 22 (visit 3)

  • Change in Percentage of Time Glucose is Above 140

    33 days after day 1

  • Number of Participants Who Reported Side Effects of Low Carbohydrate Eating and CGM at Health Check Phone Call

    Approximately 5 days each new sensor is placed (days 5 and 16)

  • +5 more secondary outcomes

Study Arms (1)

Normal Diet + CGM then low carb + CGM

EXPERIMENTAL

Phase I (part 1) - regular diet: Patients will wear a CGM sensor (with no real time feedback) for 11 days; document what they eat on a food log; and rate their postprandial fatigue and cravings. Phase II (part 2) - low carb diet: Patients will wear a CGM sensor (with real time feedback) for 11 days; document what they eat on a food log; and rate their postprandial fatigue and cravings; document their blood sugar before and two hours after eating (as well as before breakfast and before going to bed).

Other: Normal DietOther: Low carb dietDevice: CGM with no real time feedbackDevice: CGM with real time feedback)Behavioral: Education material

Interventions

Phase I (regular diet): all participants will eat their normal diet and will log their food.

Normal Diet + CGM then low carb + CGM

Phase II (low carb diet): participants will be asked to eat a low carb diet and log their food

Normal Diet + CGM then low carb + CGM

Phase I will collect CGM without real time feedback

Normal Diet + CGM then low carb + CGM

Phase II participants will be asked to scan their sensor at least every eight hours and document their blood sugar before and two hours after eating as well as before breakfast and before going to bed.

Normal Diet + CGM then low carb + CGM

Phase I: participants will be given the book Always Hungry and be asked to read chapters 1-5 after a health check phone call approximately 5 days after the sensor is placed. Phase II: participants will be taught about carbohydrates and the benefits and side effects. Additionally, they will be given multiple resources to assist them regarding carbohydrates as well as a book entitled "The Calorie King, Calories, Fat, and Carbohydrates." Groceries will also be delivered for 2 recipes that the participants choose from to make.

Normal Diet + CGM then low carb + CGM

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A1C Glucose Measurement between 5.7 to 6.4 (for most recent A1C test, not older than 1 year)
  • No diabetes medication including Metformin
  • BMI (body mass index) \>30
  • Must speak, read, and write in English
  • No current pregnancy or breastfeeding
  • Must not classify as either Vegan or Vegetarian
  • Must be a patient at the Livonia Health Center

You may not qualify if:

  • previous bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Michigan

Livonia, Michigan, 48152, United States

Location

MeSH Terms

Conditions

Glucose Intolerance

Interventions

Continuous Glucose Monitoring

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicInvestigative Techniques

Limitations and Caveats

This was a small pilot study to test feasibility of CGM. No statistical analysis was conducted because of the small sample size.

Results Point of Contact

Title
Spring Stonebraker
Organization
University of Michigan

Study Officials

  • Caroline Richardson, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Max and Buena Lichter Research Professor of Family Medicine, Assistant Chair, Department of Family Medicine and Professor of Family Medicine, Medical School

Study Record Dates

First Submitted

October 2, 2018

First Posted

October 4, 2018

Study Start

October 16, 2018

Primary Completion

March 7, 2019

Study Completion

September 26, 2019

Last Updated

March 16, 2020

Results First Posted

March 16, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

No plan to share IPD

Locations